Our pharmaceuticals and healthcare business operates in the field of research, production, and sales of pharmaceuticals and healthcare products, boasting unique competitiveness in product innovation, large-scale manufacturing, product distribution, and foreign trade. It is a leading R&D, production, and sales service provider in segment markets like medical apparatus and instruments, nutritional ingredients, food additives and medicine. We deliver professional solutions to our customers.
Through R&D and innovation efforts and industrial mergers and acquisitions, Sinochem Health Co., Ltd. (a subsidiary of Sinochem International) has developed into an industry-leading service provider covering the full service chain. The company integrates R&D, production and sales across the fields of medical devices, nutritional raw materials, food additives, and pharmaceuticals. Our health segment focuses on the nutrition and health business, whereby we provide innovative raw materials for the betterment of human health and a high quality of life. Currently, the company holds a strong market position in the field of bone and joint products and possesses a high potential for growth. Chondroitin and glucosamine, which are the key star products of the company, dominate the top three spots in terms of domestic market share in North America and Europe. Meanwhile, natural high-intensity sweetener, which is the company's third-ranked key product, has pretty good potential and prospects for development. Our export volume of stevia has consistently ranked top among Chinese enterprises in recent years.
Our pharmaceutical segment mainly deals with pharmaceutical and medical device-related products. With state-of-the-art professional technology and excellent after-sales service, our medical device business has seen the establishment of partnerships with many reputable local and international medical device companies. With the continuous introduction of new categories, this business segment currently deals with several specializations such as orthopedics, cardiology, gastroenterology and neurosurgery. In the future, a national medical device application platform will also be developed. Meanwhile, the pharmaceutical business primarily services the European, American, Japanese and Korean markets, with its total export volume ranking among the top in the industry. It provides reputable international pharmaceutical customers with comprehensive supply chain solutions and pharmaceutical regulatory services that fulfill the requirements of different countries.
Integrated solutions for orthopedic devices